Fang Zhong-Ying, Zhang Miao, Liu Jia-Ning, Zhao Xue, Zhang Yong-Qing, Fang Lei
School of Biological Sciences and Technology, University of Jinan, Jinan, China.
School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China.
Front Pharmacol. 2021 Jan 14;11:611087. doi: 10.3389/fphar.2020.611087. eCollection 2020.
Tanshinone IIA (Tan IIA) is a pharmacologically lipophilic active constituent isolated from the roots and rhizomes of the Chinese medicinal herb Bunge (Danshen). Tan IIA is currently used in China and other neighboring countries to treat patients with cardiovascular system, diabetes, apoplexy, arthritis, sepsis, and other diseases. Recently, it was reported that tan IIA could have a wide range of antitumor effects on several human tumor cell lines, but the research of the mechanism of tan IIA is relatively scattered in cancer. This review aimed to summarize the recent advances in the anticancer effects of tan IIA and to provide a novel perspective on clinical use of tan IIA.
丹参酮IIA(Tan IIA)是从中药材丹参(Bunge)的根及根茎中分离出的具有药理亲脂性的活性成分。Tan IIA目前在中国及其他周边国家用于治疗心血管系统疾病、糖尿病、中风、关节炎、败血症及其他疾病的患者。最近,有报道称Tan IIA对多种人类肿瘤细胞系具有广泛的抗肿瘤作用,但Tan IIA在癌症方面的作用机制研究相对分散。本综述旨在总结Tan IIA抗癌作用的最新进展,并为Tan IIA的临床应用提供新的视角。